glutamic acid has been researched along with Cystic Periventricular Leukomalacia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Beeraka, NM; Bulygin, KV; Fan, R; Greeshma, MV; Huria, T; Kumar, P; Liu, J; Nikolenko, VN; Sinelnikov, MY; Sukocheva, O; Uthaiah, CA; Vikram, PRH | 1 |
| Jensen, FE; Kinney, HC; Rosenberg, PA; Volpe, JJ | 1 |
| Bonnier, C; Carpentier, S; Gressens, P; Henin, D; Mesplès, B | 1 |
| Fontaine, RH; Gressens, P; Mesplès, B; Plaisant, F | 1 |
| Arzimanoglou, A; Baud, O; Gressens, P; Sfaello, I | 1 |
| Back, SA | 1 |
| Gorna, A; Gressens, P; Griesmaier, E; Keller, M; Sarkozy, G; Simbruner, G; Urbanek, M; Yang, J | 1 |
| Evrard, P; Gressens, P; Lamboley, G | 1 |
| Volpe, JJ | 1 |
5 review(s) available for glutamic acid and Cystic Periventricular Leukomalacia
| Article | Year |
|---|---|
Recent Investigations on Neurotransmitters' Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies-Glia Dynamics in Stem Cell Therapy.
Topics: Brain Injuries; Cell- and Tissue-Based Therapy; Cerebral Palsy; Glutamic Acid; Humans; Infant; Infant, Newborn; Leukomalacia, Periventricular; Neuroglia; Neurotransmitter Agents; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; White Matter | 2022 |
The developing oligodendrocyte: key cellular target in brain injury in the premature infant.
Topics: Animals; Brain Injuries; Glutamic Acid; Humans; Hypoxia-Ischemia, Brain; Immunity, Innate; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Microglia; Oligodendroglia; Reactive Oxygen Species | 2011 |
Pathophysiology of neonatal brain lesions: lessons from animal models of excitotoxicity.
Topics: Animals; Animals, Newborn; Cerebral Palsy; Cytokines; Disease Models, Animal; Glutamic Acid; Humans; Infant, Newborn; Inflammation; Interleukin-9; Leukomalacia, Periventricular; Mice; Microglia; Models, Neurological | 2005 |
Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms.
Topics: Adenosine; Cytokines; Disease Progression; Female; Glutamic Acid; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Leukomalacia, Periventricular; Magnetic Resonance Imaging; Obstetric Labor Complications; Oligodendroglia; Pregnancy; Pregnancy Complications | 2006 |
Neurobiology of periventricular leukomalacia in the premature infant.
Topics: Animals; Brain; Cerebral Hemorrhage; Female; Fetal Diseases; Glutamic Acid; Humans; Infant, Newborn; Infant, Premature; Leukomalacia, Periventricular; Pregnancy; Pregnancy Complications, Infectious; Regional Blood Flow | 2001 |
4 other study(ies) available for glutamic acid and Cystic Periventricular Leukomalacia
| Article | Year |
|---|---|
Delayed white matter injury in a murine model of shaken baby syndrome.
Topics: Animals; Animals, Newborn; Brain; Brain Stem; Cell Death; Cerebellum; Corpus Callosum; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Infant, Newborn; Leukomalacia, Periventricular; Male; Mice; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Shaken Baby Syndrome; Time Factors | 2002 |
Topiramate prevents excitotoxic damage in the newborn rodent brain.
Topics: Alanine; Animals; Animals, Newborn; Brain; Cerebral Palsy; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Fructose; Glutamic Acid; Humans; Hypoxia, Brain; Ibotenic Acid; Infant, Newborn; Leukomalacia, Periventricular; Male; Mice; Neuroprotective Agents; Neurotoxins; Rats; Rats, Sprague-Dawley; Topiramate; Treatment Outcome | 2005 |
Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice.
Topics: Animals; Animals, Newborn; Brain; Cytoprotection; Disease Models, Animal; Drug Administration Schedule; Erythropoietin; Female; Glutamic Acid; Humans; Ibotenic Acid; Infant, Newborn; Injections, Intraventricular; Leukomalacia, Periventricular; Male; Mice; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Receptors, Erythropoietin; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Time Factors | 2006 |
[Prenatal inhibition of intestinal vasoactive peptide and cerebral excitatory lesions in the newborn mouse].
Topics: Animals; Animals, Newborn; Cerebral Palsy; Disease Models, Animal; Drug Evaluation, Preclinical; Embryonic and Fetal Development; Excitatory Amino Acids; Female; Glutamic Acid; Humans; Ibotenic Acid; Infant, Newborn; Leukomalacia, Periventricular; Mice; Mice, Inbred Strains; Neuroprotective Agents; Pregnancy; Vasoactive Intestinal Peptide | 1999 |